Chengdu Push Bio-technology Competitors and Similar CompaniesClear all
Chengdu Push Bio-technology's competitors and similar companies include Fortrea, Novartis and Hutchison China Meditech.
 Chengdu Push Bio-technology Chengdu Push Bio-technology (成都普思生物科技股份有限公司) is a provider of separation and purification of natural medicines and pharmaceutical research services. |  Fortrea Fortrea Holdings (formerly known as Labcorp Clinical Development and Commercialization Services) is a contract research organization (CRO). |  Novartis Novartis is a company that researches, develops, manufactures, and markets healthcare products. |  Hutchison China Meditech Hutchison China MediTech is a biopharmaceutical company, engaging in the research, development, manufacture and sale of pharmaceuticals and healthcare products. | |
Founding Date | Founding Date 2005 | Founding Date 2023 | Founding Date 1996 | Founding Date 2000 |
Type | Type Private | Type Public | Type Public | Type Public |
Tags | ||||
Locations | Locations Cheng Du Shi, CN HQ | Locations Durham, US HQ Buenos Aires, AR Melbourne, AU Sydney, AU Zaventem, BE Sao Paulo, BR Sofia, BG see more | Locations Basel, CH HQ Tirana, AL Buenos Aires, AR Macquarie Park, AU Kundl, AT Unterlangkampfen, AT Wien, AT see more | Locations Shanghai, CN HQ Beijing, CN Jiangsu, CN Shanghai, CN Shanghai, CN Hong Kong, HK Hong Kong, HK see more |
Employees | Employees N/A | Employees 19,000 | Employees 75,883 | Employees 1,811 |
Valuation ($) | Valuation ($) N/A | Valuation ($) 1.6 b | Valuation ($) N/A | Valuation ($) 3.6 b |
Financial | ||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $2.7b (FY, 2025) | Revenue (est.) $56.7b (FY, 2025) | Revenue (est.) $548.5m (FY, 2025) |
Cost of goods | Cost of goods N/A | Cost of goods N/A | Cost of goods $8.4b (FY, 2025) | Cost of goods $324.4m (FY, 2025) |
Gross profit | Gross profit N/A | Gross profit N/A | Gross profit $49.8b (FY, 2025) | Gross profit $224.2m (FY, 2025) |
Net income | Net income N/A | Net income ($986.2m) (FY, 2025) | Net income $14b (FY, 2025) | Net income $435.1m (FY, 2025) |
Funding | ||||
Total funding raised | Total funding raised N/A | Total funding raised N/A | Total funding raised $ 6.5m | Total funding raised $ 100m |
For sources of this data, please see the company profile
View Company Profiles
Fortrea
HQ
Durham, US
Employees
19,000
Fortrea Holdings (formerly known as Labcorp Clinical Development and Commercialization Services) is a contract research organization (CRO).
View companyNovartis
HQ
Basel, CH
Employees
75,883
Novartis is a company that researches, develops, manufactures, and markets healthcare products.
View companyHutchison China Meditech
HQ
Shanghai, CN
Employees
1,811
Hutchison China MediTech is a biopharmaceutical company, engaging in the research, development, manufacture and sale of pharmaceuticals and healthcare products.
View company